Cinclus Pharma
Phase 1A Swedish pharma company bringing relief to the world with the clinical stage drug candidate linaprazan glurate for gastric acid related diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $75M
About
A Swedish pharma company bringing relief to the world with the clinical stage drug candidate linaprazan glurate for gastric acid related diseases.
Small Molecules
Funding History
2Total raised:$75M
Series B$50MDec 15, 2021
Series A$25MJun 15, 2019